ArticleNucleic acids research2026
ATACdb 2.0: a comprehensive chromatin accessibility database of human and mouse.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Chromatin accessibility, which reflects transcriptional activity, is crucial for elucidating gene regulation, cellular function, and disease mechanisms. To provide a more comprehensive chromatin accessibility resource, we have released ATACdb 2.0 (https://www.licpathway.net/ATACdb/), which provides multiple significant improvements over ATACdb 1.0: (i) Substantially expands the data scale by adding new mouse data and expanding human samples, while constructing pseudo-bulk ATAC-seq profiles based on scATAC-seq data to enrich cell type diversity. The current version contains 319 968 559 chromatin accessibility regions (CARs) from 4 031 human samples and 75 639 252 CARs from 1273 mouse samples. Compared with version 1.0, the numbers of samples and regions have increased by 3.5- and 7.5-fold, respectively. (ii) Provides richer genetic and epigenetic regulatory annotations, including silencer regions, CpG islands, meQTLs, histone modifications, eRNAs, transcription co-factors (TcoFs) and transcription factors (TFs), etc. (iii) Adds practical and convenient search and analysis functions, including "Search by SNP", "Genomic regions enrichment analysis", and "Gene-CARs overlapping analysis". (iv) Optimized target gene identification methods and added enrichment analysis of target genes. (v) Provides two additional data quality control metrics. In summary, ATACdb 2.0 provides more comprehensive and reliable resources along with more convenient and flexible functionalities, facilitating the exploration of the role of chromatin accessibility in gene regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.